Altre lingue EQL Pharma AB

Azioni

EQL

SE0005497732

Prezzo di chiusura NORDIC GROWTH MARKET Altri mercati azionari 00:00:00 25/04/2024			Variaz. 5gg	Var. 1 gen.
43 ^SEK	-0,92%		+1,90%	+28,74%

22/04	EQL Pharma AB (Publ) annuncia il lancio di Mellozzan (Melatonina) in Germania e Austria	CI
13/02	EQL Pharma AB (publ) fornisce una guida alle vendite per l'anno 2023/24	CI

Altre lingue

Sblocca tutte le notizie su tutte le aziende: non perdere mai più un'opportunità di investimento redditizia!

Registrazione 100% gratuita

Mellozzan[® ](melatonin) launched in Germany and Austria	22/04
EQL Pharma AB Announces Mellozzan Launched in Germany and Austria	22/04
Mellozzan[® ](melatonin) have gained marketing approval in the UK	14/03
Nomination committee for the 2024 Annual General Meeting	16/02
EQL Pharma: Q3 numbers supportive of inflection point	14/02
Interim Report April - December 2023	13/02
EQL Pharma AB Provides Sales Guidance for the Year 2023/24	13/02
EQL Pharma AB Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023	13/02
Invitation to presentation in connection with EQL Pharma's quarterly report, third quarter, 2023/24	30/01
EQL Pharma: Growth and margin inflection point – Q3(23/24) preview	24/01
EQL Pharma: A repeat prescription for growth	23/11
EQL Pharma again appointed Gazelle company in Skåne by Dagens Industri and once again places itself in 6th place out of 98 Skåne Gazelles	20/11
Interim Report April - September 2023	17/11
EQL Pharma AB Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2023	17/11
Invitation to presentation in connection with EQL Pharma's quarterly report, second quarter, 2023/24	06/11
EQL Pharma Plans 2024 Launch of Melatonin Product in Germany, Austria After Marketing Approvals	06/10/23
Mellozzan[® ](melatonin) have gained marketing approval in Germany and Austria	06/10/23
EQL Pharma AB Announces its Mellozzan Gains Marketing Approval by Health Authorities in Germany and Austria	06/10/23
EQL Pharma : Annual report 2022/2023	25/08/23
Bulletin from the annual general meeting in EQL Pharma AB on 17 August 2023	17/08/23

Non ci sono risultati per questa ricerca

Tutte le notizie Raccomandazione analisti Eventi più importanti Insiders Resoconti Comunicati stampa Pubblicazioni ufficiali Altre lingue Idee di trading Articoli MarketScreener Analisi MarketScreener

Altre lingue EQL Pharma AB

Azioni

EQL

SE0005497732

Altre lingue

Filtri